Our working hypothesis is as follows: a limited panel of accessible markers (FSH, varicocele, DNA fragmentation) could significantly improve the initial triage of infertile patients, particularly in resource-limited settings where specialized tests are not always readily available. The gene discussed is BRD2; the disease is Infertility.